Discover the latest news from ROIS below

ROIS CDMO closes on the acquisition of US Injectable Manufacturing Facility

ROIS, the CDMO arm of ROVI and a leader in injectable manufacturing, today announces closing the acquisition of a state-of-the-art injectable drug product manufacturing and packaging site in Phoenix, Arizona (USA) from Bristol Myers Squibb.

ROIS Appoints Kimberlee Steele as Chief Commercial Officer

ROIS today announced the appointment of Kimberlee Steele as Chief Commercial Officer, effective from 1 March 2026.

ROIS Reflects on 2025: Innovation, Investment and Global Growth

From major investments to global expansion, 2025 marked a defining year in ROIS’s continued evolution as a leading injectable CDMO.